Paper8555470
Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.
Brodsky RA and 2 others. Blood, 1996. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Papers, record 8555470. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8555470
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Aplastic | Major topic |
| Cyclophosphamide | Major topic |
| Immunosuppressive Agents | Major topic |
| Acquired Immunodeficiency Syndrome | |
| Adolescent | |
| Adult | |
| Bone Marrow | |
| Child | |
| Cyclosporine | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Regeneration | |
| Remission Induction | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA15396 | NCI NIH HHS | United States | P01CA015396 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00005778 | High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide | Background |
Source ClinicalTrials.gov
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41694401 | Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694401 | PubMed |
| 39576169 | High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review. | Eur J Rheumatol | 2024 | https://conductscience.org/library/papers/39576169 | PubMed |
| 38669341 | Modified Delphi panel consensus recommendations for management of severe aplastic anemia. | Blood Adv | 2024 | https://conductscience.org/library/papers/38669341 | PubMed |
| 33113600 | [How I treat refractory sever aplastic anemia]. | Zhonghua Xue Ye Xue Za Zhi | 2020 | https://conductscience.org/library/papers/33113600 | PubMed |
| 29143887 | Diagnosis and Treatment of Aplastic Anemia. | Curr Treat Options Oncol | 2017 | https://conductscience.org/library/papers/29143887 | PubMed |
| 29100887 | A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment. | Antiviral Res | 2017 | https://conductscience.org/library/papers/29100887 | PubMed |
| 28975138 | High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies. | Neurol Neuroimmunol Neuroinflamm | 2017 | https://conductscience.org/library/papers/28975138 | PubMed |
| 28228650 | Haematopoietic stem cell transplantation for autoimmune diseases. | Nat Rev Rheumatol | 2017 | https://conductscience.org/library/papers/28228650 | PubMed |
| 27589232 | Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/27589232 | PubMed |
| 27467367 | High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia. | J Pediatr Hematol Oncol | 2016 | https://conductscience.org/library/papers/27467367 | PubMed |
| 23605367 | The optimal immunosuppressive therapy for aplastic anemia. | Int J Hematol | 2013 | https://conductscience.org/library/papers/23605367 | PubMed |
| 23358715 | Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases. | Am J Blood Res | 2013 | https://conductscience.org/library/papers/23358715 | PubMed |
| 23222381 | Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab). | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23222381 | PubMed |
| 22053283 | Aplastic anemia: immunosuppressive therapy in 2010. | Pediatr Rep | 2011 | https://conductscience.org/library/papers/22053283 | PubMed |
| 21865410 | Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance. | Mult Scler | 2012 | https://conductscience.org/library/papers/21865410 | PubMed |
| 21495931 | Clinical management of aplastic anemia. | Expert Rev Hematol | 2011 | https://conductscience.org/library/papers/21495931 | PubMed |
| 21447004 | Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. | Eur J Haematol | 2011 | https://conductscience.org/library/papers/21447004 | PubMed |
| 21358440 | High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases. | Medicine (Baltimore) | 2011 | https://conductscience.org/library/papers/21358440 | PubMed |
| 21295330 | High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease. | Semin Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21295330 | PubMed |
| 21169833 | High-dose chemotherapy and multiple sclerosis. | Curr Opin Oncol | 2011 | https://conductscience.org/library/papers/21169833 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8555470
GET https://conductscience.org/api/papers/v1/8555470/cited_by?page=2